Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
35 readers recommended
A new premixed, liquid glucagon coming in October in a prefilled syringe and in 2020 as an auto-injector. The second stable glucagon approved this year
28 readers recommended
By Becky Milner A company called Intarcia has developed a GLP-1 mini-pump that is implanted under the skin to continuously provide medication for six months at a time –...
25 readers recommended
These new rules will save both consumers and health plan providers thousands of dollars a year through pre-deductible coverage of chronic condition treatments
24 readers recommended
New guidelines from ADA and EASD focus on GLP-1 agonists and SGLT-2 inhibitors to improve heart and kidney health
25 readers recommended
Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...
42 readers recommended
Read on to learn about the research around GLP-1, SGLT-2, and combination therapy use in type 1 diabetes. Dr. Paresh Dandona is a Distinguished Professor and Chief of...
24 readers recommended
Beginning in 2020, nation-wide Cigna (and Express Scripts) and three Minnesota insurance companies (Blue Cross and Blue Shield, Medica, and UCare) will cap total monthly...
29 readers recommended
FDA approval the fast-acting insulin for children means that children will have more flexibility in their mealtime insulin dosing
30 readers recommended
The diaTribe team was in Barcelona for the 55 th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the...
35 readers recommended
A few weeks ago, Kelly experienced severe hypoglycemia (she left her RileyLink in her basement by accident!) – lucky for her, she had just picked up a new emergency...
28 readers recommended
As we enter hurricane season, here are three important steps people with diabetes can take to prepare for natural disasters
32 readers recommended
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...
27 readers recommended
Read about the approval of Rybelsus, the first oral GLP-1 agonist, here . “I do think this is a great day for people with diabetes. I do hope that primary care providers...
81 readers recommended
Ozempic, a once weekly injectable GLP-1 agonist drug, is now approved to reduce the risk of heart attack and stroke. Rybelsus (a pill version of Ozempic) is confirmed to...
40 readers recommended
An oral (pill) version of Ozempic, Rybelsus, becomes the first GLP-1 agonist pill for type 2 diabetes
46 readers recommended
Will the medication move from “off label” to standard of care for people at high risk of developing type 2 diabetes?
39 readers recommended
New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...
27 readers recommended
A new pill combines Jardiance, Tradjenta, and metformin to help people with type 2 diabetes manage blood glucose levels more easily, and in many different ways
21 readers recommended
The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...